Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01940185 · ClinicalTrials.gov registry record
A Post-Approval Study of the LINX® Reflux Management System
A clinical trial, sponsored by Torax Medical Incorporated.
- Completed
- Registry status
- 200
- Enrollment target
NCT01940185 is a clinical trial that has completed, run by Torax Medical Incorporated. The registered enrollment target is 200 participants.
The verdict
NCT01940185 has completed, sponsored by Torax Medical Incorporated.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
A Post-Approval Study of the LINX® Reflux Management System in a prospective, multicenter, single-arm study, with patients as their own control to monitor the safety and efficacy of the LINX implant procedure and device in a post-approval environment to supplement existing safety and efficacy data.
Interventions
- DEVICE LINX device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-06-30 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01940185
The ClinicalTrials.gov registry entry for NCT01940185 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Torax Medical Incorporated, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LINX device is the first listed.
NCT01940185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01940185 about?
NCT01940185 is a clinical study titled "A Post-Approval Study of the LINX® Reflux Management System". A Post-Approval Study of the LINX® Reflux Management System in a prospective, multicenter, single-arm study, with patients as their own control to monitor the safety and efficacy of the LINX implant procedure and device in a post-approval environment to supplement existing safety and efficacy data.
What is the current status of trial NCT01940185?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2012-06-30. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT01940185?
The interventions under investigation include: LINX device (DEVICE).
Who is sponsoring clinical trial NCT01940185?
This trial is sponsored by Torax Medical Incorporated, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.